Company Profile (AI Text)
Name: Rexis Biotech, Inc.
Canonical URL: https://wefunder.com/rexis
Updated at: 2026-06-02T05:01:21Z

Tagline: Making your drinks taste better, your medicine work better & your drugs more fun

Key claims:
- Total raised on Wefunder: 507889 | citation: https://wefunder.com/rexis#claim-total-raised
- Total investors: 207 | citation: https://wefunder.com/rexis#claim-total-investors

Verified facts:
- Total raised on Wefunder: 507889 | observed_at: 2026-06-02T05:01:21Z | expires_at: 2026-06-03T05:01:21Z
- Total investors: 207 | observed_at: 2026-06-02T05:01:21Z | expires_at: 2026-06-03T05:01:21Z

Computed metrics:
- total_amount_raised: 507889
- total_investors: 207
- team_size: 5
- featured_investor_count: 2
- faq_count: 5
- recent_post_count: 0

Quick facts:
- Cash flow positive in under 6 months with estimated gross revenue projection of USD $3.2 in 2023* | citation: https://wefunder.com/rexis#claim-fact-1
- $450k initial seed round investment from Virgin Beverages, 3CHI Group, The Manning Foundation | citation: https://wefunder.com/rexis#claim-fact-2
- Signed contracts in the first half of 2023 worth over USD $8,350,000 | citation: https://wefunder.com/rexis#claim-fact-3
- 6 trade secret processes make up our highly defensible IP catalog | citation: https://wefunder.com/rexis#claim-fact-4
- Founder was CEO of Virgin Entertainment Canada, Cineplex, BOSCH; led companies to successful IPO | citation: https://wefunder.com/rexis#claim-fact-5
- Executive team with experience on Fortune 500 brands: Red Bull, Virgin, Best Buy, MillerCoors, NBCU | citation: https://wefunder.com/rexis#claim-fact-6
- Our technology enhances the functionality, taste, and efficacy of everyday consumable products | citation: https://wefunder.com/rexis#claim-fact-7
- Powering recognizable brands Happy Valley, First Person Group, 3CHI (Kyle Busch’s #8 NASCAR sponsor) | citation: https://wefunder.com/rexis#claim-fact-8

FAQ:
- Q: Hi. The scope of your technology seems immense. How do you plan on mitigating the risks of overdose when you combine you solution with potentially dangerous drugs? Will this not require specific trials to understand what a safe and therapeutic level will be?
  A: Hello Asad, I appreciate your knowledgeable question. You are absolutely correct, depending on the therapeutic use for the technology clinical trials may or may not be required. We use our technology in therapeutic / medicinal applications such as heart medications cognitive function drugs and epilepsy however we also use it in consumer packaged goods such as beverages. If the application is a true medicinal application such as a pharmaceutical base then clinical trials are used to determine ...
- Q: Hello, When do you plan to have your Form C filed with the SEC? Although I'm considering investing in your company, I won't pull the trigger until I review the official filing. Thank you
  A: Hello Scott, Thank you for your interest in what we are doing here at Rexis, and thank you for this question. My apologies for the late reply, I was waiting for concrete information from our accounting team before posting. We expect our Form C to be filed with the SEC within 2-3 weeks. Please "Follow For Updates" and you will be notified as updates continue to come through.
- Q: What is the projected growth for Rexis?
  A: Rexis has revenue generation in several industries but the Hemp beverage industry alone is expected to exceed 3 billion in 2024, of which we are poised to control over 15% of market share.. Rexis, without question is the fastest growing Hemp beverage company in the world.
- Q: Very interesting. Do you have any patents/defendable IP?
  A: Luca, we rely on patents and Trade Secrets. We have a 7-step process that is coupled with a proprietary ingredient portfolio that helps ensure our process is protected. If one part of our tech was somehow duplicated, there would be virtually no chance the rest of the process could be replicated. We never produce our complete ingredient list in one facility. We have adopted the Coke model; we have primary ingredients manufactured in separate facilities helping to ensure confidentiality. If you...
- Q: Psilocybin was interesting to see on the pitch as well as the market size estimate. Are you anticipating/on the way to having something ready for when the FDA approves it for Depression? Psilocybin is schedule 1 so would you not need a DEA license to work with it at all?
  A: Orion, I do apologize I missed this question. There are several legal Psilocybin derivates we have been developing in other countries where the research and development aspects are with less restrictions than the US. You are 100% correct, we are working to prefect the mechanism of actions for the molecules once they have been approved. We have been working with several of the large firms in the Psilocybin industry to help further develop just such an application.